Published on
July 24, 2024
- 12:45 GMT
Revolo Announces New Data Further Validating the Upstream Mechanism of Action and Subcutaneous Administration of ‘1104
Reduction of key proteins in the interleukin 4 (IL-4) and IL-13 signalling pathway via SHP-1 activation is a key component involved in the mechanism of action of ‘1104 First-in-class upstream approach uniquely affects both the effector and regulatory arms …
Distribution channels:
Technology
...
